What are the treatment options for Chlamydia and gonorrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Chlamydia and gonorrhea are treated with antibiotics, with specific regimens depending on the infection, and the most effective treatment options include azithromycin or doxycycline for chlamydia, and ceftriaxone for gonorrhea, as recommended by the US Centers for Disease Control and Prevention 1. The treatment of chlamydia and gonorrhea involves the use of antibiotics to eliminate the bacteria causing the infection.

  • For chlamydia, the recommended treatment options include azithromycin 1 gram as a single oral dose, or doxycycline 100 mg taken orally twice daily for 7 days, with azithromycin being a more cost-effective option in many settings, especially for patients who may not complete the full 7-day doxycycline regimen 1.
  • For gonorrhea, the recommended treatment is ceftriaxone 500 mg as a single intramuscular injection, which is effective against the bacteria Neisseria gonorrhoeae 1. It is essential to complete the full course of antibiotics, even if symptoms resolve earlier, to ensure that the infection is fully cleared and to prevent the development of antibiotic resistance.
  • Patients should also be instructed to abstain from sexual intercourse for 7 days after single-dose therapy or until completion of a 7-day regimen, and until all of their sex partners are treated, to minimize the risk of reinfection 1.
  • Follow-up testing is recommended 3 months after treatment to confirm cure, especially for gonorrhea, due to increasing antibiotic resistance 1. These infections can lead to serious complications, including pelvic inflammatory disease and infertility, if left untreated, emphasizing the importance of prompt and effective treatment.
  • The US Centers for Disease Control and Prevention recommends routine screening of all sexually active women 25 years of age or younger, and other asymptomatic women at increased risk for infection, to detect and treat chlamydia and gonorrhea early, and prevent long-term complications 1.

From the FDA Drug Label

Erythromycins tablets are indicated for treatment of the following infections caused by Chlamydia trachomatis: conjunctivitis of the newborn, pneumonia of infancy, and urogenital infections during pregnancy When tetracyclines are contraindicated or not tolerated, erythromycin tablets are indicated for the treatment of uncomplicated urethral, endocervical, or rectal infections in adults due to Chlamydia trachomatis. Acute pelvic inflammatory disease caused by Neisseria gonorrhoeae: Erythrocin® Lactobionate-I.V. (erythromycin lactobionate for injection, USP) followed by erythromycin base orally, as an alternative drug in treatment of acute pelvic inflammatory disease caused by N. gonorrhoeae in female patients with a history of sensitivity to penicillin Urethritis and cervicitis due to Chlamydia trachomatis or Neisseria gonorrhoeae.

Treatment options for Chlamydia and gonorrhea include:

  • Erythromycin tablets for the treatment of Chlamydia trachomatis infections, including urogenital infections during pregnancy and uncomplicated urethral, endocervical, or rectal infections in adults.
  • Erythromycin lactobionate for injection, USP followed by erythromycin base orally for the treatment of acute pelvic inflammatory disease caused by Neisseria gonorrhoeae.
  • Azithromycin for the treatment of urethritis and cervicitis due to Chlamydia trachomatis or Neisseria gonorrhoeae 2, 3.

From the Research

Treatment Options for Chlamydia and Gonorrhea

  • Chlamydia trachomatis and Neisseria gonorrhoeae are two common sexually transmitted diseases that can be treated with various antibiotics 4, 5, 6, 7, 8.
  • Azithromycin is a commonly used antibiotic for the treatment of Chlamydia and gonorrhea, with a single 1g dose showing similar effectiveness as a 7-day regimen of doxycycline 4, 7, 8.
  • For gonorrhea, azithromycin 2g and ceftriaxone 250mg are equally effective in treating uncomplicated gonorrhea, with azithromycin having the advantage of oral administration and efficacy against concomitant chlamydial infection 6.
  • Other treatment options for gonorrhea include ofloxacin 400mg bid for seven days, and single dose cephalosporins such as cefixime 400mg, cefuroxime axetil 1g, and cefpodoxime proxetil 200mg 5.
  • It is essential to note that the development of resistance to antibiotics is a concern, and treatment should be guided by local resistance patterns and patient factors 5, 6.

Efficacy of Azithromycin

  • Azithromycin has been shown to be effective in eradicating Chlamydia trachomatis and Neisseria gonorrhoeae, with high tissue bioavailability and a tissue half-life of between 2 and 4 days 7.
  • A single 1g oral dose of azithromycin is as effective as a standard 7-day twice daily regimen of doxycycline in eradicating uncomplicated chlamydial genital infections 7, 8.
  • Azithromycin is also effective against other sexually transmitted pathogens that are often present concurrently, making it a useful option for treatment 7.

Comparison of Treatment Regimens

  • A randomized, unblinded, comparative trial involving 597 patients demonstrated that single 1g oral azithromycin is equivalent to standard therapy with doxycycline 100mg twice daily for seven days in treating uncomplicated urogenital chlamydial infection 8.
  • Another study compared the efficacy and tolerance of single-dose treatment of uncomplicated gonorrhea with azithromycin 2g and ceftriaxone 250mg, showing that both treatments are equally effective 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.